Literature DB >> 15131073

Divergence of renal vascular endothelial growth factor mRNA expression and protein level in post-ischaemic rat kidneys.

Adám Vannay1, Andrea Fekete, Csaba Adori, Tibor Tóth, György Losonczy, Lajos László, Barna Vásárhelyi, Tivadar Tulassay, András Szabó.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent regulator of angiogenesis and vascular protection. Synthesis of VEGF is induced by hypoxia and different cytokines including interleukin-6 (IL-6) and interleukin-1beta (IL-1beta). However, post-ischaemic alterations of this growth factor in the kidney are incompletely known. To determine VEGF synthesis in renal ischaemia/reperfusion (I/R) injury unilateral warm ischaemia was induced by cross-clamping the left renal pedicle for 55 min followed by 2 and 24 h of reperfusion (T2 and T24 kidneys; n= 6 in each group). Sham-operated, non-clamped animals served as controls (n= 6). Renal VEGF, IL-6 and IL-1beta mRNA expression were determined by reverse transcription-polymerase chain reaction (RT-PCR). VEGF protein level and distribution were determined by Western blot and immunohistochemical analysis. Immunohistochemistry revealed prominent VEGF staining in the outer medulla of control, T2 and T24 kidneys. VEGF immunoreactivity accumulated at the basolateral area of tubular epithelial cells in T2 kidneys, while it was diffuse in control and T24 kidneys. VEGF protein levels were increased 2- to 3-fold in T2 and T24 kidneys (both P < 0.01 versus controls), while VEGF mRNA expression remained unchanged. IL-6 mRNA expression was increased (P < 0.01 versus controls) in T2 kidneys, while IL-1beta mRNA expression remained unchanged. Increased VEGF protein levels but not mRNA expression suggests that during renal I/R injury VEGF synthesis in kidneys--unlike in other organs--is primarily regulated at a post-transcriptional level. As IL-6 mRNA expression increased simultaneously with VEGF protein levels, the post-ischaemic regulation of IL-6 and VEGF synthesis might be interrelated in rat kidney. Copyright 2004 The Physiological Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131073     DOI: 10.1113/expphysiol.2004.027516

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  6 in total

1.  Protective effect of milk fat globule-epidermal growth factor-factor VIII after renal ischemia-reperfusion injury in mice.

Authors:  Akihisa Matsuda; Rongqian Wu; Asha Jacob; Hidefumi Komura; Mian Zhou; Zhimin Wang; Md Monowar Aziz; Ping Wang
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

Review 2.  Pathophysiology of ischemic acute kidney injury.

Authors:  Asif A Sharfuddin; Bruce A Molitoris
Journal:  Nat Rev Nephrol       Date:  2011-03-01       Impact factor: 28.314

3.  Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens.

Authors:  Gisele V Oliveira; Hal K Hawkins; David Chinkes; Ann Burke; Andre Luiz Pasqua Tavares; Marcia Ramos-e-Silva; Thomas B Albrecht; Gregory T Kitten; David N Herndon
Journal:  Int Wound J       Date:  2009-12       Impact factor: 3.315

4.  Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.

Authors:  Erinn B Rankin; John E Tomaszewski; Volker H Haase
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

5.  Stromal cell-derived factor-1 (SDF1)-dependent recruitment of bone marrow-derived renal endothelium-like cells in a mouse model of acute kidney injury.

Authors:  Hiroyuki Ohnishi; Shinya Mizuno; Yoko Mizuno-Horikawa; Takashi Kato
Journal:  J Vet Med Sci       Date:  2015-03       Impact factor: 1.267

Review 6.  A Detailed Overview About the Single-Cell Analyses of Solid Tumors Focusing on Colorectal Cancer.

Authors:  William J Kothalawala; Barbara K Barták; Zsófia B Nagy; Sára Zsigrai; Krisztina A Szigeti; Gábor Valcz; István Takács; Alexandra Kalmár; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2022-07-14       Impact factor: 2.874

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.